ATE279194T1 - Behandlung von rückenmarkverletzungenbedingter impotenz - Google Patents

Behandlung von rückenmarkverletzungenbedingter impotenz

Info

Publication number: ATE279194T1
Authority: AT; Austria
Prior art keywords: spinal cord; cord injury; impotency; treatment; male
Prior art date: 1998-02-23

Application number

AT99301085T

Other languages

English (en)

Inventor

Murray Craig Maytom

Ian Howard Osterloh

Original Assignee

Pfizer Ireland Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-23

Filing date

1999-02-15

Publication date

2004-10-15

1999-02-15 Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals

2004-10-15 Application granted granted Critical

2004-10-15 Publication of ATE279194T1 publication Critical patent/ATE279194T1/de

Links

208000020431 spinal cord injury Diseases 0.000 title abstract 2
241001465754 Metazoa Species 0.000 abstract 2
201000001880 Sexual dysfunction Diseases 0.000 abstract 2
231100000872 sexual dysfunction Toxicity 0.000 abstract 2
ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical class C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Electrotherapy Devices (AREA)

AT99301085T 1998-02-23 1999-02-15 Behandlung von rückenmarkverletzungenbedingter impotenz ATE279194T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7558098P	1998-02-23	1998-02-23

Publications (1)

Publication Number	Publication Date
ATE279194T1 true ATE279194T1 (de)	2004-10-15

Family

ID=22126701

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99301085T ATE279194T1 (de)	1998-02-23	1999-02-15	Behandlung von rückenmarkverletzungenbedingter impotenz

Country Status (17)

Country	Link
US (1)	US20060040935A1 (de)
EP (1)	EP0951908B1 (de)
JP (1)	JPH11315025A (de)
KR (1)	KR19990072798A (de)
AT (1)	ATE279194T1 (de)
AU (1)	AU755402B2 (de)
CA (1)	CA2262268C (de)
DE (1)	DE69921008T2 (de)
DK (1)	DK0951908T3 (de)
ES (1)	ES2226281T3 (de)
HU (1)	HUP9900438A3 (de)
IL (1)	IL128532A0 (de)
MY (1)	MY133446A (de)
NZ (1)	NZ334333A (de)
PT (1)	PT951908E (de)
TW (1)	TW542719B (de)
ZA (1)	ZA991393B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403597B1 (en)	1997-10-28	2002-06-11	Vivus, Inc.	Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6548490B1 (en)	1997-10-28	2003-04-15	Vivus, Inc.	Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
GT199900061A (es) *	1998-05-15	2000-10-14	Pfizer	Formulaciones farmaceuticas.
US6200591B1 (en) *	1998-06-25	2001-03-13	Anwar A. Hussain	Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834506A1 (de) *	1998-07-31	2000-02-03	Hexal Ag	Transmucosales therapeutisches System zur Anwendung von Sildenafil
DE19834507A1 (de) *	1998-07-31	2000-02-03	Hexal Ag	Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
EP1173167A4 (de)	1999-04-30	2004-07-14	Lilly Icos Llc	Behandlung der störungen der weiblichen erregbarkeit
EP1244673A2 (de)	1999-12-24	2002-10-02	Bayer Aktiengesellschaft	Imidazo[1,3,5]triazinone und ihre verwendung
KR20010016165A (ko) *	2000-11-16	2001-03-05	정순학	성기능 장애 치료를 위한 피부에 적용하는 제제
KR100393160B1 (ko) *	2001-06-14	2003-07-31	한국과학기술연구원	신규한 피라졸로피리미딘티온 유도체, 그의 제법 및발기부전 치료제로서의 용도
WO2002102385A1 (en) *	2001-06-14	2002-12-27	Sampad Bhattacharya	Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis
CN101027061B (zh)	2004-05-11	2014-03-12	情感智能有限责任公司	药物制剂及其在治疗女性性功能障碍中的应用
EP1790343A1 (de)	2005-11-11	2007-05-30	Emotional Brain B.V.	Pharmazeutische Zusammensetzungen und deren Verwendung zur Behandlung sexueller Störungen der Frau
EP1925307A1 (de)	2006-11-03	2008-05-28	Emotional Brain B.V.	Verwendung von 3-alpha-androstanediol zur Behandlung sexueller Dysfunktion
WO2008142396A1 (en) *	2007-05-18	2008-11-27	Anthony Denis Maher	Methods of assessing male fertility using a uridine marker

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9114760D0 (en) *	1991-07-09	1991-08-28	Pfizer Ltd	Therapeutic agents
GB9301192D0 (en) *	1993-06-09	1993-06-09	Trott Francis W	Flower shaped mechanised table
GB9423911D0 (en) *	1994-11-26	1995-01-11	Pfizer Ltd	Therapeutic agents

1999
- 1999-01-29 TW TW088101404A patent/TW542719B/zh not_active IP Right Cessation
- 1999-02-15 ES ES99301085T patent/ES2226281T3/es not_active Expired - Lifetime
- 1999-02-15 AT AT99301085T patent/ATE279194T1/de not_active IP Right Cessation
- 1999-02-15 PT PT99301085T patent/PT951908E/pt unknown
- 1999-02-15 DE DE69921008T patent/DE69921008T2/de not_active Expired - Lifetime
- 1999-02-15 DK DK99301085T patent/DK0951908T3/da active
- 1999-02-15 EP EP99301085A patent/EP0951908B1/de not_active Expired - Lifetime
- 1999-02-15 IL IL12853299A patent/IL128532A0/xx unknown
- 1999-02-19 MY MYPI99000595A patent/MY133446A/en unknown
- 1999-02-19 CA CA002262268A patent/CA2262268C/en not_active Expired - Lifetime
- 1999-02-20 KR KR1019990005672A patent/KR19990072798A/ko not_active Ceased
- 1999-02-22 HU HU9900438A patent/HUP9900438A3/hu unknown
- 1999-02-22 JP JP11043205A patent/JPH11315025A/ja active Pending
- 1999-02-22 ZA ZA9901393A patent/ZA991393B/xx unknown
- 1999-02-23 AU AU18390/99A patent/AU755402B2/en not_active Ceased
- 1999-02-23 NZ NZ334333A patent/NZ334333A/xx unknown
2005
- 2005-10-24 US US11/257,797 patent/US20060040935A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DK0951908T3 (da)	2004-12-27
PT951908E (pt)	2005-01-31
HU9900438D0 (en)	1999-04-28
CA2262268C (en)	2003-07-29
MY133446A (en)	2007-11-30
ES2226281T3 (es)	2005-03-16
TW542719B (en)	2003-07-21
IL128532A0 (en)	2000-01-31
JPH11315025A (ja)	1999-11-16
EP0951908A3 (de)	2000-08-16
HUP9900438A2 (hu)	2000-03-28
US20060040935A1 (en)	2006-02-23
CA2262268A1 (en)	1999-08-23
DE69921008D1 (de)	2004-11-18
ZA991393B (en)	2000-08-22
KR19990072798A (ko)	1999-09-27
AU1839099A (en)	1999-09-09
NZ334333A (en)	2000-11-24
AU755402B2 (en)	2002-12-12
HUP9900438A3 (en)	2002-01-28
EP0951908A2 (de)	1999-10-27
EP0951908B1 (de)	2004-10-13
DE69921008T2 (de)	2006-02-02

Legal Events

Date

Code

Title

Description

2005-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0951908

Country of ref document: EP

2009-11-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69921008D1 (de)	2004-11-18	Behandlung von Rückenmarkverletzungenbedingter Impotenz
PA8476301A1 (es)	2000-09-29	Formulaciones intranasales para tratar trastornos sexuales
ATE233091T1 (de)	2003-03-15	Verwendung von histamine-2 agonisten zur behandlung sexueller funktionsstörungen
DE602004029369D1 (de)	2010-11-11	Halbfeste mukoadhäsive formulierungen
ATE245650T1 (de)	2003-08-15	Pyrazolopyimidinon-derivate zur behandlung von impotenz
DE69434218D1 (de)	2005-02-10	Photodynamische behandlung von synovium
ID24184A (id)	2000-07-13	Obat untuk perawatan disfungsi ereksi
EP1108426A3 (de)	2002-10-02	Anwendung von Prostaglandinagonisten zur Behandlung der Erektionstörungen und Impotenz
PT1109814E (pt)	2004-08-31	5-heterociclil pirazol¬4,3-d\|pirimidina-7-onas para o tratamento da disfuncao erectil masculina
DK1150698T3 (da)	2006-01-16	Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktion
DE60138385D1 (de)	2009-05-28	Heilmittel zur behandlung von erkrankungen des sehnervs
WO2000053148A3 (en)	2000-12-14	Methods and compositions for treating erectile dysfunction
MD1979F1 (en)	2002-08-31	Method of secondary cataract treatment
GB2277265A (en)	1994-10-26	Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema
ATE367823T1 (de)	2007-08-15	E-selectin zur behandlung oder vorbeugung von schlaganfall
WO2005051368A3 (en)	2006-03-09	Phosphodiesterase v inhibitor formulations
DE60109594D1 (de)	2005-04-28	R-eliprodil zur behandlung von glaucoma
WO1996036339A3 (en)	1997-02-13	Use of dihydrotestosterone compounds for treating male sexual dysfunction
ATE144141T1 (de)	1996-11-15	Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz
RU93058537A (ru)	1996-10-10	Применение атипамезола для лечения мужской сексуальной импотенции
UA3777U (uk)	2004-12-15	Спосіб лікування еректильної дисфункції
ECSP993027A (es)	1999-08-12	Formulaciones intranasales para trastornos sexuales
PT1355650E (pt)	2006-05-31	Combinacao de ingredientes activos contendo alfuzosina e apomorfina